| 000 | 01578 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516091754.0 | ||
| 264 | 0 | _c20130418 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1463-1326 | ||
| 024 | 7 |
_a10.1111/j.1463-1326.2012.01617.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDuong, J K | |
| 245 | 0 | 0 |
_aMetformin therapy in patients with chronic kidney disease. _h[electronic resource] |
| 260 |
_bDiabetes, obesity & metabolism _cOct 2012 |
||
| 300 |
_a963-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcidosis, Lactic _xblood |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aLactic Acid _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetformin _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRenal Dialysis |
| 650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xblood |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aRoberts, D M | |
| 700 | 1 | _aFurlong, T J | |
| 700 | 1 | _aKumar, S S | |
| 700 | 1 | _aGreenfield, J R | |
| 700 | 1 | _aKirkpatrick, C M | |
| 700 | 1 | _aGraham, G G | |
| 700 | 1 | _aWilliams, K M | |
| 700 | 1 | _aDay, R O | |
| 773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 14 _gno. 10 _gp. 963-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1463-1326.2012.01617.x _zAvailable from publisher's website |
| 999 |
_c21761026 _d21761026 |
||